Nuwellis to Present Innovations at ROTH Healthcare Conference in 2024

Nuwellis, Inc., a medical technology company based in Minneapolis, is focused on addressing fluid overload in patients. On September 25, 2024, the company announced that its President and CEO, Nestor Jaramillo, will participate in the third annual ROTH Healthcare Opportunities Conference, scheduled for October 9, 2024. This event is organized by ROTH Capital Partners and aims to provide a platform for healthcare companies to present their innovations and engage with investors. The conference will feature investor presentations, and materials related to Nuwellis' participation will be accessible on the company's investor relations website. Interested parties can attend the conference by contacting their ROTH representative or reaching out to Vivian Cervantes from the Gilmartin Group for registration. Nuwellis is known for its Aquadex SmartFlow® System, which is designed for managing fluid overload in both adult and pediatric patients. This system is particularly beneficial for patients who do not respond to traditional medical management, including diuretics. The device can be used temporarily for up to eight hours or extended for longer durations in hospitalized patients. The participation of Nuwellis at this conference highlights the company's commitment to innovation in medical technology and its ongoing efforts to improve patient outcomes. By engaging with investors and showcasing their advancements, Nuwellis aims to strengthen its position in the healthcare market and continue its mission of transforming the lives of patients suffering from fluid overload.